THE SURVIVAL RATE OF LC IS 15.5%.
THAT’S UNACCEPTABLE. WE’RE
HERE TO CHANGE THAT.

 

Biodesix launches cancer test

biodesix_logoBiodesix Inc. in Broomfield has launched a test to help oncologists guide treatment of patients with lung cancer.

Biodesix’s VeriStrat is a blood-based test for patients with advanced stage nonsmall cell lung cancer. The test can identify how a patient will react, good or bad, to certain cancer treatments.

 

Trackback

 

Leave a Reply